Cargando…

Probiotics for the Prevention of Antibiotic-Associated Diarrhea

Several communities have started using probiotic-rich fermented foods as therapeutic options with presumed medicinal powers. We now know the importance of microbiome balance and how probiotics can restore imbalances in the microbiome. Probiotics have been tested for a number of clinical uses such as...

Descripción completa

Detalles Bibliográficos
Autores principales: Kopacz, Kira, Phadtare, Sangita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9408191/
https://www.ncbi.nlm.nih.gov/pubmed/36011108
http://dx.doi.org/10.3390/healthcare10081450
_version_ 1784774546963824640
author Kopacz, Kira
Phadtare, Sangita
author_facet Kopacz, Kira
Phadtare, Sangita
author_sort Kopacz, Kira
collection PubMed
description Several communities have started using probiotic-rich fermented foods as therapeutic options with presumed medicinal powers. We now know the importance of microbiome balance and how probiotics can restore imbalances in the microbiome. Probiotics have been tested for a number of clinical uses such as the prevention of antibiotic-associated diarrhea (AAD), the treatment of various diseases such as H. pylori infection, irritable bowel disease, vaginitis, the prevention of allergies, and necrotizing enterocolitis in newborns. AAD has been the most indicated therapeutic use for probiotics. AAD is a common side effect of antibiotic usage, which affects up to 30% of patients. The hypothesis behind using probiotics for AAD is that they help normalize an unbalanced flora. There are many potential mechanisms by which probiotics support intestinal health such as (i) boosting immunity, (ii) increasing gut barrier integrity, (iii) producing antimicrobial substances, (iv) modulating the gut microbiome, (v) increasing water absorption, and (vi) decreasing opportunistic pathogens. Many randomized-controlled trials including the strain-specific trials that use Lactobacillus and Saccharomyces and meta-analyses have shown the benefits of probiotics in addressing AAD. Although adverse events have been reported for probiotics, these are broadly considered to be a safe and inexpensive preventative treatment option for AAD and other gastrointestinal disorders.
format Online
Article
Text
id pubmed-9408191
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-94081912022-08-26 Probiotics for the Prevention of Antibiotic-Associated Diarrhea Kopacz, Kira Phadtare, Sangita Healthcare (Basel) Review Several communities have started using probiotic-rich fermented foods as therapeutic options with presumed medicinal powers. We now know the importance of microbiome balance and how probiotics can restore imbalances in the microbiome. Probiotics have been tested for a number of clinical uses such as the prevention of antibiotic-associated diarrhea (AAD), the treatment of various diseases such as H. pylori infection, irritable bowel disease, vaginitis, the prevention of allergies, and necrotizing enterocolitis in newborns. AAD has been the most indicated therapeutic use for probiotics. AAD is a common side effect of antibiotic usage, which affects up to 30% of patients. The hypothesis behind using probiotics for AAD is that they help normalize an unbalanced flora. There are many potential mechanisms by which probiotics support intestinal health such as (i) boosting immunity, (ii) increasing gut barrier integrity, (iii) producing antimicrobial substances, (iv) modulating the gut microbiome, (v) increasing water absorption, and (vi) decreasing opportunistic pathogens. Many randomized-controlled trials including the strain-specific trials that use Lactobacillus and Saccharomyces and meta-analyses have shown the benefits of probiotics in addressing AAD. Although adverse events have been reported for probiotics, these are broadly considered to be a safe and inexpensive preventative treatment option for AAD and other gastrointestinal disorders. MDPI 2022-08-02 /pmc/articles/PMC9408191/ /pubmed/36011108 http://dx.doi.org/10.3390/healthcare10081450 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Kopacz, Kira
Phadtare, Sangita
Probiotics for the Prevention of Antibiotic-Associated Diarrhea
title Probiotics for the Prevention of Antibiotic-Associated Diarrhea
title_full Probiotics for the Prevention of Antibiotic-Associated Diarrhea
title_fullStr Probiotics for the Prevention of Antibiotic-Associated Diarrhea
title_full_unstemmed Probiotics for the Prevention of Antibiotic-Associated Diarrhea
title_short Probiotics for the Prevention of Antibiotic-Associated Diarrhea
title_sort probiotics for the prevention of antibiotic-associated diarrhea
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9408191/
https://www.ncbi.nlm.nih.gov/pubmed/36011108
http://dx.doi.org/10.3390/healthcare10081450
work_keys_str_mv AT kopaczkira probioticsforthepreventionofantibioticassociateddiarrhea
AT phadtaresangita probioticsforthepreventionofantibioticassociateddiarrhea